Long-term efficacy of brodalumab in ustekinumab-responsive patients with moderate-to-severe psoriasis

被引：0
|
作者：
Green, Lawrence [1 ]
Hsu, Sylvia [2 ]
Papp, Kim A. [3 ]
Rastogi, Shipra [4 ]
Pillai, Radhakrishnan [5 ]
Israel, Robert J. [6 ]
机构：
[1] George Washington Univ, Sch Med, Washington, DC 20052 USA
[2] Temple Univ, Sch Med, Philadelphia, PA 19122 USA
[3] Prob Med Res, Waterloo, ON, Canada
[4] Ortho Dermatol, Bridgewater, MA USA
[5] Dow Pharmaceut Sci, Petaluma, CA USA
[6] Valeant Pharmaceut North Amer, Bridgewater, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6832
引用
收藏
页码：AB181 / AB181
页数：1
相关论文
共 50 条
  • [41] A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
    Emily K. Haque
    Aaminah Azhar
    John Corbett
    Jillian Frieder
    Xuan Wang
    Alan Menter
    Dermatology and Therapy, 2020, 10 : 1121 - 1135
  • [42] The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis
    Sawyer, Laura
    Fotheringham, Iain
    Wright, Emily
    Yasmeen, Najeeda
    Gibbons, Carl
    Moller, Anders Holmen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (06) : 557 - 568
  • [43] A network meta-analysis of long-term efficacy and safety of treatments for moderate-to-severe plaque psoriasis
    Armstrong, A.
    Soliman, A.
    Betts, K.
    Wang, Y.
    Gao, Y.
    Stakias, V.
    Puig, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E33 - E33
  • [44] A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
    Haque, Emily K.
    Azhar, Aaminah
    Corbett, John
    Frieder, Jillian
    Wang, Xuan
    Menter, Alan
    DERMATOLOGY AND THERAPY, 2020, 10 (05) : 1121 - 1135
  • [45] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia, Attia
    Abushouk, Abdelrahman Ibrahim
    Ahmed, Hussien
    Gadelkarim, Mohamed
    Elgebaly, Ahmed
    Hassan, Zeinab
    Abdel-Daim, Mohamed M.
    Negida, Ahmed
    CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 439 - 451
  • [46] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia Attia
    Abdelrahman Ibrahim Abushouk
    Hussien Ahmed
    Mohamed Gadelkarim
    Ahmed Elgebaly
    Zeinab Hassan
    Mohamed M. Abdel-Daim
    Ahmed Negida
    Clinical Drug Investigation, 2017, 37 : 439 - 451
  • [47] Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study
    Mark G. Lebwohl
    Andrew Blauvelt
    Alan Menter
    Kim A. Papp
    Scott Guenthner
    Radhakrishnan Pillai
    Robert J. Israel
    Abby Jacobson
    American Journal of Clinical Dermatology, 2019, 20 : 863 - 871
  • [48] Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study
    Lebwohl, Mark G.
    Blauvelt, Andrew
    Menter, Alan
    Papp, Kim A.
    Guenthner, Scott
    Pillai, Radhakrishnan
    Israel, Robert J.
    Jacobson, Abby
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (06) : 863 - 871
  • [49] Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis
    Ferrandiz, C.
    Garcia, A.
    Blasco, A. J.
    Lazaro, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (06) : 768 - 777
  • [50] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Wollenberg, Andreas
    Paller, Amy S.
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Oland, Christian Bjerregard
    Taveira, Christian Moreira
    Gjerum, Le
    Blauvelt, Andrew
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
12345